AGITG 2013* A phase III randomised study of BBI608 and best supportive care versus placebo and best supportive care in patients with pretreated advanced colorectal carcinoma (10542)
10:30 AM
A phase III randomised study of Cetuximab and best supportive care versus best supportive care in patients with pre-treated metastatic epidermal growth factor receptor (EGFR) positive colorectal carcinoma (10543)
10:30 AM
ICECREAM: The Irinotecan Cetuximab Evaluation and the Cetuximab Response Evaluation Among Patients with G13D Mutation. A randomised Phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic CRC with either KRAS WT or G13D mutation. (10544)
10:30 AM
PETACC6 - Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer (10545)
10:30 AM
The CHALLENGE Trial. A Phase III Study of the Impact of a Physical Activity Program on Disease-Free Survival in Patient with High Risk Stage II or Stage III Colon Cancer: A Randomised Controlled Trial (10546)
10:30 AM